These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26397771)

  • 1. TNF-α exerts higher cytotoxic effect on MCF-7 multidrug resistant derivative, role of Akt activation.
    Ghandadi M; Haj-Ali N; Behravan J; Abnous K; Mohammadi A; Gharaee ME; Mosaffa F
    Breast Dis; 2015; 35(4):241-7. PubMed ID: 26397771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α exerts cytotoxic effects on multidrug resistant breast cancer MCF-7/MX cells via a non-apoptotic death pathway.
    Ghandadi M; Behravan J; Abnous K; Ehtesham Gharaee M; Mosaffa F
    Cytokine; 2017 Sep; 97():167-174. PubMed ID: 28651126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive Oxygen Species Mediate TNF-x237A; Cytotoxic Effects in the Multidrug-Resistant Breast Cancer Cell Line MCF-7/MX.
    Ghandadi M; Behravan J; Abnous K; Mosaffa F
    Oncol Res Treat; 2016; 39(1-2):54-9. PubMed ID: 26890889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha induces stronger cytotoxicity in ABCG2-overexpressing resistant breast cancer cells compared with their drug-sensitive parental line.
    Mosaffa F; Kalalinia F; Parhiz BH; Behravan J
    DNA Cell Biol; 2011 Jun; 30(6):413-8. PubMed ID: 21323575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT.
    Machuca C; Mendoza-Milla C; Córdova E; Mejía S; Covarrubias L; Ventura J; Zentella A
    BMC Cell Biol; 2006 Feb; 7():9. PubMed ID: 16504042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Akt phosphorylation attenuates resistance to TNF-α cytotoxic effects in MCF-7 cells, but not in their doxorubicin resistant derivatives.
    Ghandadi M; Mohammadi A; Behravan J; Abnous K; Haj-Ali N; Gharaee ME; Mosaffa F
    Iran J Basic Med Sci; 2016 Dec; 19(12):1363-1367. PubMed ID: 28096970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling.
    Yang X; Ding Y; Xiao M; Liu X; Ruan J; Xue P
    Chem Biol Interact; 2017 Dec; 278():22-31. PubMed ID: 28987325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinib.
    Ando K; Ohmori T; Inoue F; Kadofuku T; Hosaka T; Ishida H; Shirai T; Okuda K; Hirose T; Horichi N; Nishio K; Saijo N; Adachi M; Kuroki T
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8872-9. PubMed ID: 16361577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
    Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells.
    Brünner-Kubath C; Shabbir W; Saferding V; Wagner R; Singer CF; Valent P; Berger W; Marian B; Zielinski CC; Grusch M; Grunt TW
    Breast Cancer Res Treat; 2011 Sep; 129(2):387-400. PubMed ID: 21046231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK and p53 stress signaling cascades are altered in MCF-7 cells resistant to tumor necrosis factor-mediated apoptosis.
    Doman RK; Perez M; Donato NJ
    J Interferon Cytokine Res; 1999 Mar; 19(3):261-9. PubMed ID: 10213465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined treatment TNF-alpha/doxorubicin alleviates the resistance of MCF-7/Adr cells to cytotoxic treatment.
    Cao W; Ma SL; Tang J; Shi J; Lu Y
    Biochim Biophys Acta; 2006 Feb; 1763(2):182-7. PubMed ID: 16483679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
    Lecour S; Suleman N; Deuchar GA; Somers S; Lacerda L; Huisamen B; Opie LH
    Circulation; 2005 Dec; 112(25):3911-8. PubMed ID: 16344382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
    Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
    Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.
    Block M; Gründker C; Fister S; Kubin J; Wilkens L; Mueller MD; Hemmerlein B; Emons G; Günthert AR
    Int J Oncol; 2012 Nov; 41(5):1845-54. PubMed ID: 22922893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
    Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
    Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: its direct inhibition by quercetin.
    Hwang MK; Song NR; Kang NJ; Lee KW; Lee HJ
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1592-600. PubMed ID: 19401153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of steroid sulfatase expression by tumor necrosis factor-α through phosphatidylinositol 3-kinase/Akt signaling pathway in PC-3 human prostate cancer cells.
    Suh BY; Jung JJ; Park N; Seong CH; Im HJ; Kwon Y; Kim D; Chun YJ
    Exp Mol Med; 2011 Nov; 43(11):646-52. PubMed ID: 21904110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.